CIK 1302573

OncoMed Pharmaceuticals Inc

EDGAR filings

Customers

0 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Mar 31, 2015

10-Q filed 2015-05-07

Customers 1

Companies OncoMed Pharmaceuticals Inc discloses as major customers, as a share of OncoMed Pharmaceuticals Inc revenue. 0 active, 1 lapsed.

Company	% of OncoMed Pharmaceuticals Inc revenue	Est. revenue	Period	Trend	Status	Source
GSK GSK plc	55%	$5.3M	3M 2015-03-31	−5.0pp	Lapsed Last seen 2015-03-31	10-Q 2015-05-07
GlaxoSmithKline LLC (“GSK”) 55 % * 10-Q filed 2015-05-07 Period 3M 2015-01-01 to 2015-03-31 (55%)Accession 0001193125-15-177276 GlaxoSmithKline LLC (“GSK”) 31 % * 65 % 10-K filed 2015-03-12 Period FY 2014-01-01 to 2014-12-31 (31%)Accession 0001193125-15-089346 GlaxoSmithKline LLC ("GSK") * 60 % 31 % 38 % 10-Q filed 2015-11-05 Period 3M 2014-07-01 to 2014-09-30 (60%)Accession 0001564590-15-009684

Alerts are coming

Get an email when OncoMed Pharmaceuticals Inc's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.